Home > Insider Trading > Filing (0001214659-22-000946)

Filing Details

Accession Number:: 0001214659-22-000946
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-01-20 16:35:38
Reporting Period:: 2022-01-18

Accepted Time:: 2022-01-20 16:35:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1581280	Twist Bioscience Corp	TWST	Biological Products, (No Disgnostic Substances) (2836)	462058888

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1753655	M. Emily Leproust	C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080	President & Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-01-18	286	$8.82	198,875	No	4	M	Direct
Common Stock	Disposition	2022-01-18	286	$60.03	198,589	No	4	S	Direct
Common Stock	Disposition	2022-01-18	579	$77.39	198,010	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2022-01-18	286	$0.00	286	$8.82

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
150,879		2027-09-28	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Remaning Holdings	Nature of Ownership
Common Stock	Employee Stock Option (right to buy)	$5.95	2025-09-28	24,360	Direct
Common Stock	Employee Stock Option (right to buy)	$26.66	2028-11-18	266,539	Direct
Common Stock	Employee Stock Option (right to buy)	$23.33	2029-10-23	131,290	Direct

Expiration Date	Remaning Holdings	Nature of Ownership
2025-09-28	24,360	Direct
2028-11-18	266,539	Direct
2029-10-23	131,290	Direct

Footnotes

The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 28, 2021.
Represents the weighted average sales price per share. The shares sold at prices ranging from $60.00 to $60.13 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.